Shares in Benchmark Holdings PLC rose 29% after the aquaculture genetics specialist announced a strategic review and formal sale process.
This decision, influenced by the board's belief that the current share price significantly undervalues Benchmark's businesses and prospects, follows three years of substantial revenue growth, improved profitability, and cash conversion.
In that time, Benchmark's revenue increased from £105.4m to £169.5m, and Adjusted EBITDA grew from £15.5m to £35.5m.
The review will explore options including selling the company wholly or in parts.
Benchmark stock rose 10p to 45p on the news.